FIELD: biotechnology.
SUBSTANCE: invention relates to production of a cell expressing Oct3/4 gene. Method comprises subjecting somatic cell or precursor cells, which are not human embryo cells, stress with low pH from 5.4 to 5.8, which is brought by ATP, in combination with a mechanical stimulus, including exposure of cells to shear stress, high pressure or their combinations.
EFFECT: invention widens the range of equipment.
15 cl, 25 dwg, 9 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS RELATING TO PLURIPOTENT CELLS | 2015 |
|
RU2711942C2 |
| DELIVERY, CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND USE IN THERAPY | 2013 |
|
RU2721275C2 |
| COMPONENTS OF THE CRISPR-CAS SYSTEM, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | 2013 |
|
RU2796549C2 |
| DNA-CONTAINING POLYNUCLEOTIDES AND GUIDE SEQUENCES FOR CRISPR TYPE V SYSTEMS AND METHODS FOR PRODUCTION AND USE THEREOF | 2021 |
|
RU2832314C1 |
| GENOMIC ENGINEERING | 2014 |
|
RU2764757C2 |
| GENOME ENGINEERING | 2021 |
|
RU2812848C2 |
| CRISPR-CAS SYSTEMS AND METHODS FOR CHANGING THE EXPRESSION OF GENE PRODUCTS | 2013 |
|
RU2796273C2 |
| CHIMERIC ANTIGEN RECEPTORS AND WAYS OF USE THEREOF | 2020 |
|
RU2841244C2 |
| SYSTEM DESIGN, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION | 2013 |
|
RU2796017C2 |
| HUMANISED M-CSF MICE | 2012 |
|
RU2730643C2 |
